“the buzz” show: immutep limited (nasdaq: immp) rise on positive breast cancer data
Published 3 years ago • 1.8K plays • Length 0:42Download video MP4
Download video MP3
Similar videos
-
7:43
immutep (asx:imm; nasdaq: immp) company update on start of 2021
-
52:08
immutep (asx:imm, nasdaq:immp) global webcast presentation at sitc 2022
-
10:01
immutep limited (asx:imm, nasdaq:immp) encouraging results for immutep's cancer therapies
-
47:53
immutep (asx:imm, nasdaq:immp) tacti-003 results, june 2024
-
7:09
immutep (asx:imm, nasdaq:immp) reports 71.4% response rate for lung cancer therapy, october 31, 2023
-
15:49
immutep (asx:imm, nasdaq:immp) - sharecafe's "hidden gems" presentation, 17 february 2023
-
28:03
$immp-spikes on positive breast cancer treatment data-$sls 130%,$immp 165%,$sgmo 55%,$veru 43%
-
0:40
false: "i am braf positive. that's bad. it means my tumor will come back."
-
2:25
bispectral index™ byte 2: the bis™ index range
-
0:35
dr. brufsky discusses bevacizumab benefits in tnbc
-
7:43
immutep (asx:imm) company update on start of 2021
-
0:38
inova breast cancer program - plastic surgeons, ali mesbahi
-
5:33
mammatyper | innovation in breast cancer diagnosis
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
46:19
waiting for mbn2020: breast implant associated - anaplastic large cell lymphoma: an overview
-
0:58
bling the bra | breast cancer awareness month 2018
-
3:25
advancing drug delivery at mit with microbubbles and ultrasound
-
15:15
advances in breast cancer technology
-
5:45
considerations for ngs testing in mtnbc